Related Experiment Video
Updated: Jun 19, 2026

Individualized Reconstitution of Human Milk Microbiota: A Feasible Approach in Real-World Settings
Published on: February 7, 2025
Changes in faecal microbiota of infants with cow's milk protein allergy--a Spanish prospective case-control 6-month
Oscar C Thompson-Chagoyan1, Jose M Vieites, Jose Maldonado
1Department of Biochemistry and Molecular Biology II, University of Granada, Granada, Spain.
Insights
Infants with cow's milk protein allergy (CMPA) exhibit distinct gut microbiota compared to healthy infants. Treatment with hydrolyzed formulae altered microbiota, showing increased lactobacilli and decreased enterobacteria and bifidobacteria in CMPA infants.
Area of Science:
- Microbiology
- Pediatrics
- Immunology
Background:
- Gut microbiota composition differs between healthy and allergic children.
- Altered microbiota patterns are postulated to be associated with allergy development.
Purpose of the Study:
- To compare fecal microbiota in healthy infants and those with cow's milk protein allergy (CMPA) at diagnosis.
- To evaluate changes in CMPA infant microbiota after 6 months of treatment with hydrolyzed formulae.
Main Methods:
- Fecal samples collected from 92 infants (46 healthy, 46 CMPA) aged 2-12 months.
- Microbiota cultured for total aerobes, anaerobes, enterobacteria, bifidobacteria, lactobacilli, clostridia, and yeasts.
- Statistical comparison of microbiota at baseline and after 6 months of treatment.
Main Results:
- CMPA infants had higher baseline total bacteria and anaerobic counts, and lower yeast counts than healthy infants.
- After 6 months, CMPA infants showed increased anaerobic and lactobacilli, and decreased bifidobacteria, enterobacteria, and yeast proportions.
- CMPA infant microbiota shifted towards increased lactobacilli and decreased enterobacteria and bifidobacteria from baseline to 6 months.
Conclusions:
- Significant differences exist in gut microbiota composition between healthy and CMPA infants.
- Treatment with extensively hydrolyzed formulae impacts the gut microbiota in CMPA infants.
- Gut microbiota composition may play a role in the development or protection against CMPA.
Abstract:
Major differences have been found in gut microbiota between healthy and allergic children, and a possible association between allergy and altered microbiota patterns have been postulated. The main object of the study was to compare the faecal microbiota between healthy and cow's milk protein allergy (CMPA) infants at the baseline immediately after the diagnosis, and to evaluate the changes in the faecal microbiota after 6 months of treatment of CMPA infants fed on extensively cow's milk protein hydrolyzed formulae without pre- or probiotics, compared with healthy children fed on standard milk formulae. The population comprised 92 infants aged 2-12 months who were non-allergic (n=46) or diagnosed with IgE-mediated CMPA (n=46). At baseline and at 6 months, faecal samples were collected into sterile plastic tubes, immediately placed into anaerobic jars and processed within 2 h of their collection. Weighed faeces samples were diluted from 10(-1) to 10(-7) and cultured in selective media for total count of aerobes, anaerobes, enterobacteria, bifidobacteria, lactobacilli, clostridia and yeasts. Samples from non-allergic and allergic infants were compared at baseline and at 6 months using appropriate statistical tests, considering p<0.05 to be significant. In comparison with healthy infants, CMPA infants had higher total bacteria and anaerobic counts and a lower yeast count at baseline, finding no difference in the proportions of each bacterial group between groups. After 6 months, CMPA infants showed higher anaerobic and lactobacilli counts, a higher proportion of lactobacilli, a lower count and proportion of bifidobacteria, and lower proportions of enterobacteria and yeasts. Comparison of faecal samples from CMPA infants between baseline and at 6 months showed an increase in count and proportion of lactobacilli and a decrease in counts and proportions of enterobacteria and bifidobacteria. Differences in the composition of gut microbiota between CMPA and healthy infants may influence in the development of or protection from this allergy.
Related Concept Videos
Development of Human Microbiota
Microbiota Modulation by Antibiotics
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the small...
Development of the Oral Microbiota
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
